AI-driven analysis finds key sepsis biomarkers and potential treatments, paving the way for more precise diagnosis and care.

Early detection of Alzheimer’s disease (AD) can improve treatment outcomes, but current testing methods still have ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...

A first-of-its-kind analysis found that people living in hotter areas experienced more molecular changes than those in cooler ...

A team of scientists at the Indiana University School of Medicine has identified that an eye condition affecting the retina, ...

The following is a summary of “Effect of blood alcohol on the diagnostic accuracy of glial fibrillary acidic protein and ...

New research reveals compelling evidence that hormone replacement therapy may offer significant cardiovascular benefits for ...

A new proteomic aging clock may predict biological age, mortality risk, and the likelihood of age-related diseases, though ...

Coronary artery disease (CAD), or the narrowing of the coronary arteries, is the leading cause of morbidity and mortality ...

Ocrelizumab treatment in Black and Hispanic patients with MS reduces NfL levels and prevents the forming of contrast-enhancing lesions and new or enlarging T2 lesions.

Normal" levels of vitamin B12 may not be enough to ward off dementia, according to researchers at University of California ...

The following is a summary of “Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection,” published in the February 2025 issue of BMC Infectious Diseases by ...